Literature DB >> 6417772

Betalactamase-producing microorganisms in recurrent tonsillitis.

K Tunér, C E Nord.   

Abstract

In 73% of 167 patients with recurrent tonsillitis, colonization with betalactamase-producing microorganisms was found. Betastreptococci group A were recovered in 6% of the patients and group C and G streptococci in 23%. Other microorganisms found were Staphylococcus aureus in 42%, Haemophilus species in 52%, bacteroides species in 80% and fusobacteria in 40%. Ninety-eight per cent of Staph. aureus, 60% of bacteroides species and 10% of fusobacteria were betalactamase-producing. Phenoxymethylpenicillin (1 g twice a day for ten days) diminished 50% of group A, C and G streptococci. No other microorganisms were affected by this antibiotic. Clindamycin (0.15 g four times a day for ten days) eradicated Staph. aureus, group A, C and G streptococci, bacteroides and fusobacteria. Haemophilus species were not affected by clindamycin. Tinidazole (1 g once a day for 10 days) diminished bacteroides and fusobacteria. Aerobic microorganisms, Staph. aureus, streptococci and Haemophilus, were not affected by tinidazole.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417772

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  14 in total

1.  Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment.

Authors:  K Tunér; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Beta-lactamase production by oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy.

Authors:  S Nyfors; E Könönen; A Takala; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  A penicillinase-producing Fusobacterium nucleatum strain isolated from blood culture.

Authors:  G Grollier; F Guilhot; Y de Rautlin de la Roy; E Benz-Lemoine
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

4.  Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.

Authors:  I Brook; J D Gilmore
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

5.  Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum.

Authors:  K Tunér; L Lindqvist; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

6.  Beta-lactamase production in the upper respiratory tract flora.

Authors:  I Eliasson; C Kamme; K Prellner
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

7.  Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.

Authors:  I Eliasson; C Kamme
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Direct and indirect pathogenicity of Branhamella catarrhalis.

Authors:  I Brook
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Isolation of Porphyromonas gingivalis strain from tubal-ovarian abscess.

Authors:  R Hirata; C Ménard; D Fournier; M A Catellani; C Mouton; M C Ferreira
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

Review 10.  The role of beta-lactamase-producing-bacteria in mixed infections.

Authors:  Itzhak Brook
Journal:  BMC Infect Dis       Date:  2009-12-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.